Who is sponsoring NCT05783336?

NCT05783336 is sponsored by University of Exeter.

What drugs are being tested in NCT05783336?

Interventions in NCT05783336: Stepping Stones and Creating Futures Plus (SSCF+).

What condition does NCT05783336 study?

NCT05783336 studies Intimate Partner Violence, Poverty.

Is NCT05783336 still recruiting?

NCT05783336 is currently completed. Last updated 8 May 2024.

Last reviewed 2024-05-08 · How we verify

NCT05783336

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stepping Stones and Creating Futures Plus Pilot

Completed NA Last updated 8 May 2024

What this trial tests

NA trial testing Stepping Stones and Creating Futures Plus (SSCF+) in Intimate Partner Violence in 323 participants. Completed in 28 November 2023.

Timeline

24 May 2023

Primary endpoint
28 November 2023

28 November 2023

Quick facts

Lead sponsor	University of Exeter
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	323
Start date	24 May 2023
Primary completion	28 November 2023
Estimated completion	28 November 2023
Sites	1 location across South Africa

Drugs / interventions tested

Stepping Stones and Creating Futures Plus (SSCF+)

Conditions studied

Intimate Partner Violence — all drugs for Intimate Partner Violence →
Poverty — all drugs for Poverty →

Sponsor

University of Exeter

Who can join

Adults 18 to 30, any sex, with Intimate Partner Violence or Poverty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomised controlled clinical trial is to test the Stepping Stones and Creating Futures Plus (SSCF+) intervention, in young (18-25 years) people living in urban informal settlements in Durban and rural communities in KwaZulu-Natal, South Africa. The main questions it aims to answer are: * Is the intervention acceptable and feasible * What is the potential effect size on key outcomes of intimate partner violence Participants will be randomised (1:1) to compare SSCF+ and a control arm to see if there are differences between the two on intimate partner violence.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Stepping Stones and Creating Futures Plus: A pilot randomised controlled trial of a co-developed intervention with young South Africans.
Gibbs A, Washington L, Mkhwanazi S, Chirwa E, et al · · 2025 · cited 3× · PMID 40267104 · DOI 10.1371/journal.pgph.0004494
Pilot cluster randomised controlled trial of Stepping Stones and Creating Futures Plus to reduce emotional dysregulation among young men in rural areas and urban informal settlements in KwaZulu-Natal Province, South Africa.
Nyoni P, Tomita A, Mkhwanazi S, Gibbs A. · · 2025 · cited 1× · PMID 39723636 · DOI 10.1177/00207640241306062
The relationship between emotional dysregulation and, HIV acquisition risk behaviours and intimate partner violence perpetration among young men in rural areas and urban informal settlements in South Africa.
Nyoni P, Gibbs A, Mkhwanazi S, Tomita A. · · 2026 · PMID 41772846 · DOI 10.1080/13548506.2026.2635751

Verify or expand the search:

Other recruiting trials for Intimate Partner Violence

Currently open trials in the same condition.

NCT07226401 — Virtual Village for Young Parents · NA · recruiting
NCT06988787 — Multifaceted Intervention to Restore Resilience and Overcome Risk · NA · recruiting
NCT05106361 — MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intim · NA · active not recruiting
NCT06074068 — Father-Focused Intervention for Reducing Family Violence and Symptoms in Children · NA · recruiting
NCT06071299 — Impact of Family-Centered Care for Intimate Partner Violence (IPV) · NA · active not recruiting

Other University of Exeter trials

Trials by the same sponsor.

NCT07457437 — Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA · recruiting
NCT06478121 — Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE) · recruiting
NCT06965699 — The Effect of a Plant-based, Protein-dense Sauce on Essential Amino Acid Concentrations and Gut Fullness in Older Adults · NA · recruiting
NCT06846294 — Obesity Prevention in Children and Young People Treated for Acute Lymphoblastic Leukaemia with ALLTogether · NA · not yet recruiting
NCT06852547 — The Effect of Ingesting a Novel Algae Protein Source on Rested and Exercised Muscle Protein Synthesis Rates in Older Adu · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05783336 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Exeter
Last refreshed: 8 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05783336.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing